Table 1.
List of adjuvants by their dominant mechanism of action
Antigen delivery systems | Immunopotentiators |
---|---|
• Electroporation |
• Alternative pathogen-associated molecular patterns (PAMPs): e.g. Cholera enterotoxin; liquenase. |
• Gene gun |
• Heat-shock proteins |
• Liposomes |
• Lysosome and endocelllular reticulum (ER) targeting agents |
• Virosomes™ |
• Saponins (Quils, QS-21) |
• ISCOMS® |
• TLRs agonists: e.g, imiquimod, oligonucleotides (CpG, etc.), double-stranded RNA (dsRNA) |
• Micro/Nanoparticles: e.g. microparticles of poly (lactide-co-glycolide) (PLG) |
• Cytokines & chemokines: e.g. IL2, IL12 and GM-CSF |
• Emulsions: e.g., MF59, Montanides |
• Treg inactivators: e.g. anti-apoptotic molecules, low-dose cyclophosphamide, antibodies anti-CD 25, -CTLA, -IL10, or -PDL-1 |
• Virus-like particles & viral/bacterial vectors | • Monophosphoryl lipid A (MPL) and synthetic derivates |
• Muramyl dipeptide (MDP) and derivatives |